Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PDE2A | O00408 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4595504 | 0.86 | SMN1; SMN2 (0.37) | LMNASMN1; SMN2CYP1A2PDE2AALDH1A1 | |
| SCHEMBL4594171 | 0.82 | PDE2A (0.33) | LMNASMN1; SMN2L3MBTL1PDE2AALDH1A1 | |
| SCHEMBL4594169 | 0.81 | KDM4E (0.33) | LMNASMN1; SMN2L3MBTL1PDE2AALDH1A1 | |
| SCHEMBL8343522 | 0.78 | LMNA (0.45) | LMNASMN1; SMN2L3MBTL1CYP1A2PDE2A | |
| SCHEMBL27607190 | 0.77 | LMNA (0.41) | LMNASMN1; SMN2L3MBTL1CYP1A2PDE2A | |
| SCHEMBL13983020 | 0.76 | TDP1 (0.44) | LMNASMN1; SMN2L3MBTL1CYP1A2PDE2A | |
| SCHEMBL10048775 | 0.76 | LMNA (0.43) | LMNASMN1; SMN2L3MBTL1CYP1A2PDE2A | |
| SCHEMBL379405 | 0.76 | SMN1; SMN2 (0.43) | LMNASMN1; SMN2L3MBTL1CYP1A2PDE2A | |
| SCHEMBL15752122 | 0.76 | LMNA (0.48) | LMNASMN1; SMN2L3MBTL1CYP1A2PDE2A | |
| SCHEMBL4918384 | 0.76 | LOXL2 (0.44) | LMNASMN1; SMN2L3MBTL1CYP1A2PDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1871746-A1 | SUBSTITUTED N-[YPYRIMIDIN-2-YLMETHYL]CARBOXAMIDES AND THEIR USE AS HERBICIDES AND PLANT GROWTH REGULATORS | Bayer CropScience Aktiengesellschaft (DE) | 2008-01-02 | — | — | EP | disclosed |
| WO-2006105862-A1 | SUBSTITUTED N-[PYRIMIDIN-2-YLMETHYL]CARBOXAMIDES AND THEIR USE AS HERBICIDES AND PLANT GROWTH REGULATORS | BAYER CROPSCIENCE AG (DE) | 2006-10-12 | — | — | WO | disclosed |
| US-20060223708-A1 | Substituted N-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators | BAYER CROPSCIENCE GMBH (DE) | 2006-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223708-A1 | Substituted N-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators | CNPY2, PRXL2A, CBR3 | LMNA 4632/4885SMN1; SMN2 4073/4885L3MBTL1 1455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.